Related Experiment Video
Updated: Apr 25, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
CRAC channels as targets for immunotherapy
Kenneth Stauderman1, Sudarshan Hebbar1, Stefan Feske2
1CalciMedica Inc., La Jolla, CA 92037, USA.
Abstract:
Ca²⁺ release-activated Ca²⁺ (CRAC) channels facilitate store-operated Ca²⁺ entry in both immune and nonimmune cells. They are crucial for the function of many immune cell types and strongly associated with the pathophysiology of immune-related disorders. Inherited null mutations in the genes encoding the CRAC channel, ORAI1, and its activator STIM1, are linked to inborn errors of immunity in patients, highlighting the essential role of these channels in immunity. Preclinical studies using knockout mice and CRAC channel inhibitors (CRACi) have further demonstrated their pivotal function in the pathophysiology of immune-related conditions, including immunity to infection, autoimmunity, allergy, and other inflammatory diseases. Clinical trials in patients with inflammatory disorders underscore the potential utility of CRACi for immunotherapy. Here, we provide an overview of CRAC channels in immune cell function, review their roles in preclinical models of immune diseases, and discuss the outcomes of clinical trials involving CRACi.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

